113-A view on drug resistance in cancer
This article addresses the multifaceted problem of drug resistance in cancer therapy. The authors articulate a framework for understanding resistance by defining its key biological determinants, including tumor burden and growth kinetics, heterogeneity, physical barriers, the immune system, and undruggable genomic drivers. They propose four general solutions to overcome resistance: earlier detection of tumors, achieving deeper therapeutic responses, continuous monitoring and adaptive interventions during therapy, and mapping cancer cell dependencies. The article emphasizes that drug…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.